Alopecia News and Research

RSS
Alopecia is the lack or loss of hair from areas of the body where hair is usually found. Alopecia can be a side effect of some cancer treatments.
Scientists attempt to slow down ageing using novel compound

Scientists attempt to slow down ageing using novel compound

Paxman's scalp cooling system shows to successfully reduce alopecia during chemotherapy in breast cancer patients

Paxman's scalp cooling system shows to successfully reduce alopecia during chemotherapy in breast cancer patients

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

FDA approves new therapy for initial treatment of soft tissue sarcoma

FDA approves new therapy for initial treatment of soft tissue sarcoma

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

JAK inhibitors may be first effective treatment for people with alopecia areata

BirchBioMed announces successful completion of Phase I trial for topical treatment to prevent scarring

BirchBioMed announces successful completion of Phase I trial for topical treatment to prevent scarring

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Scalp cooling provides safe, effective treatment in prevention of chemotherapy-induced alopecia

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Reducing hair loss during chemotherapy: an interview with Richard Paxman

Reducing hair loss during chemotherapy: an interview with Richard Paxman

Cobimetinib with vemurafenib may have added benefit in melanoma with BRAF V600 mutation

Cobimetinib with vemurafenib may have added benefit in melanoma with BRAF V600 mutation

New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- metastatic breast cancer

New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- metastatic breast cancer

Paxman wins ‘Partnership with Academia Award’ for improving patient care with Huddersfield University

Paxman wins ‘Partnership with Academia Award’ for improving patient care with Huddersfield University

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Pfizer’s IBRANCE (palbociclib) now approved for use in women with HR+, HER2- metastatic breast cancer

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss

FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss

Combining medications may increase HBsAg loss in HBV patients

Combining medications may increase HBsAg loss in HBV patients

Heightened levels of psychological stress associated with skin complaints in college students

Heightened levels of psychological stress associated with skin complaints in college students